Taking people in TürkiyeNo phase
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Key facts
- Who runs it
- Pamukkale University
- Where
- Denizli, TürkiyeSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 31 Jan 2022
- Expected to end
- 20 Dec 2028
- Type of study
- Interventional
- Treatments tested
- intracochlear platelet rich fibrin administration
- Record updated
- 14 July 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients with sensorineural hearing loss
- Patients who will have cochlear implant surgery with CI422 electrode
Who cannot take part
- Patients with cochlear abnormality
- Patients with auditory neuropathy
Where in Türkiye
- Pamukkale UniversityDenizli, TürkiyeContact: Fazil N Ardic, MDTaking people
About the trial
What the trial wants to find out
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
The group in the trial
- intracochlear prf administration groupTreatment being tested
Treatment: intracochlear platelet rich fibrin administration
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 14 July 2026